Simplex Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,834
| Closed | -$91K | – | 11099 |
|
|
2021
Q1 | $91K | Buy |
3,834
+2,211
| +136% | +$41.1K | ﹤0.01% | 5891 |
|
|
2020
Q4 | $0 | Sell |
1,623
-10,476
| -87% | -$139K | ﹤0.01% | 9427 |
|
|
2020
Q3 | $0 | Buy |
12,099
+9,268
| +327% | +$142K | ﹤0.01% | 8879 |
|
|
2020
Q2 | $41K | Sell |
2,831
-50,727
| -95% | -$515K | ﹤0.01% | 5670 |
|
|
2020
Q1 | $220K | Buy |
+53,558
| New | +$251K | ﹤0.01% | 3484 |
|
|
2019
Q4 | – | Sell |
-1,612
| Closed | -$9K | – | 8294 |
|
|
2019
Q3 | $9K | Sell |
1,612
-845
| -34% | -$5.27K | ﹤0.01% | 6343 |
|
|
2019
Q2 | $15K | Sell |
2,457
-1,153
| -32% | -$8.12K | ﹤0.01% | 5863 |
|
|
2019
Q1 | $25K | Buy |
+3,610
| New | +$23.8K | ﹤0.01% | 5572 |
|
|
2017
Q3 | – | Sell |
-2,622
| Closed | -$31K | – | 6959 |
|
|
2017
Q2 | $31K | Buy |
2,622
+490
| +23% | +$6.26K | ﹤0.01% | 2865 |
|
|
2017
Q1 | $27K | Buy |
2,132
+1,632
| +326% | +$19.6K | ﹤0.01% | 2962 |
|
|
2016
Q4 | $6K | Buy |
500
+133
| +36% | +$1.58K | ﹤0.01% | 4260 |
|
|
2016
Q3 | $4K | Sell |
367
-5,930
| -94% | -$57.2K | ﹤0.01% | 4562 |
|
|
2016
Q2 | $54K | Buy |
6,297
+54
| +0.9% | +$370 | ﹤0.01% | 1982 |
|
|
2016
Q1 | $32K | Buy |
6,243
+5,673
| +995% | +$31.6K | ﹤0.01% | 2386 |
|
|
2015
Q4 | $4K | Buy |
+570
| New | +$4.38K | ﹤0.01% | 4105 |
|
|
2015
Q3 | – | Sell |
-200
| Closed | -$1K | – | 6464 |
|
|
2015
Q2 | $1K | Buy |
+200
| New | +$2.02K | ﹤0.01% | 4889 |
|
Simplex Trading's GNMK Position: Q2 2021 in Review
Simplex Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 3,834 shares — an estimated $91K sold.
Simplex Trading first reported a position in GNMK in Q2 2015 and held it in 16 quarters. The position peaked at $220K in Q1 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Simplex Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 3,834 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $91K.
- Simplex Trading first reported a position in GenMark Diagnostics, Inc in Q2 2015 and held it in 16 quarters.
- Simplex Trading's GenMark Diagnostics, Inc position peaked at $220K in Q1 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.